Table 1 Study population
No. | Sex | Age | Primary disease | PD duration | Albumin | BUN | Creatinine | Calcium | Phosphate | Hemoglobin | PET |
|---|---|---|---|---|---|---|---|---|---|---|---|
(months) | (g/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (mg/dL) | (g/dL) | category | ||||
1 | Male | 78 | HTN | 26 | 3.1 | 73 | 10.54 | 8.3 | 6.8 | 10.3 | HA |
2 | Female | 52 | PCKD | 1 | 3.8 | 71 | 8.35 | 9.1 | 5.2 | 10.3 | Low |
3 | Male | 66 | DN | 39 | 2.6 | 68 | 7.95 | 7.6 | 5.6 | 10.3 | HA |
4 | Male | 76 | CGN | 108 | 3 | 58 | 9.9 | 8.4 | 6.2 | 13.1 | HA |
5 | Male | 53 | DN | 42 | 3.7 | 43 | 8.6 | 8.6 | 4.3 | 11.6 | HA |
6 | Male | 46 | HTN | 50 | 3.6 | 47 | 9.67 | 8.5 | 5.6 | 12.1 | HA |
7 | Male | 64 | DN | 44 | 3.2 | 64 | 6.02 | 8.5 | 5.5 | 10.1 | HA |
8 | Male | 69 | PCKD | 20 | 3.2 | 40 | 7.93 | 8.1 | 3.8 | 12 | HA |
9 | Male | 70 | DN | 7 | 3.2 | 52 | 2.91 | 8.6 | 3.2 | 11.8 | HA |
10 | Male | 65 | CGN | 65 | 3.6 | 73.5 | 11 | 9.5 | 5.7 | 10.2 | HA |